Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
1.640
+0.040 (2.50%)
Mar 10, 2026, 4:00 PM EDT - Market closed
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of $149.94 million as of March 10, 2026. Its market cap has decreased by -22.03% in one year.
Market Cap
149.94M
Enterprise Value
111.69M
1-Year Change
-22.03%
Ranking
Category
Stock Price
$1.64
Market Cap Chart
Since April 25, 2013, Innate Pharma's market cap has increased from $125.22M to $149.94M, an increase of 19.75%. That is a compound annual growth rate of 1.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 149.94M | -13.52% |
| Dec 31, 2025 | 173.38M | 4.71% |
| Dec 31, 2024 | 165.58M | -29.08% |
| Dec 29, 2023 | 233.49M | -17.19% |
| Dec 30, 2022 | 281.97M | -29.50% |
| Dec 31, 2021 | 399.94M | 19.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Karyopharm Therapeutics | 160.88M |
| Milestone Pharmaceuticals | 160.50M |
| Immunic | 160.47M |
| Rani Therapeutics Holdings | 157.98M |
| Fate Therapeutics | 154.63M |
| Zentalis Pharmaceuticals | 148.60M |
| Corbus Pharmaceuticals Holdings | 148.41M |
| Unicycive Therapeutics | 141.63M |